Amy Brault

Pfizer, Inc. - Medicine Design

235 East 42 Street

New York, NY 10017

United States

SCHOLARLY PAPERS

1

DOWNLOADS

3

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (1)

1.

Human Amyotrophic Lateral Sclerosis Excitability Phenotype Screen: Target Discovery and Validation

Number of pages: 30 Posted: 26 May 2020
Harvard University - F.M. Kirby Neurobiology Center, Harvard University - F.M. Kirby Neurobiology Center, Pfizer, Inc. - Medicine Design, Pfizer, Inc. - Medicine Design, Pfizer, Inc. - Rare Diseases Research, Pfizer, Inc. - Centers for Therapeutic Innovation (CTI), Pfizer, Inc. - Medicine Design, Pfizer Centers for Therapeutic Innovation (CTI), Pfizer, Inc. - Medicine Design, Pfizer Centers for Therapeutic Innovation (CTI), Pfizer Centers for Therapeutic Innovation (CTI), Harvard University - F.M. Kirby Neurobiology Center, Harvard University - Department of Stem Cell and Regenerative Biology, Harvard University - F.M. Kirby Neurobiology Center, Harvard University - F.M. Kirby Neurobiology Center, Harvard University - F.M. Kirby Neurobiology Center, Harvard University - F.M. Kirby Neurobiology Center, Harvard University - Department of Stem Cell and Regenerative Biology, Harvard University - F.M. Kirby Neurobiology Center, Harvard University - F.M. Kirby Neurobiology Center, Harvard University - Department of Stem Cell and Regenerative Biology and Children's Hospital Boston - F.M. Kirby Neurobiology Center
Downloads 3 (684,241)

Abstract:

Loading...

ALS, hyperexcitability, phenotypic screen, high throughput, high content, AMPA, Kv7, D2 receptor